Evidence map›Paper›PMID 36547424›Full record

ArticleJournal of cardiovascular development and disease2022

Long COVID-19 Myocarditis and Various Heart Failure Presentations: A Case Series.

Justyna Rohun, Karolina Dorniak, Anna Faran, Anna Kochańska, Dariusz Zacharek, Ludmiła Daniłowicz-Szymanowicz

Abstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Observational
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Justyna RohunDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-214 Gdansk, Poland.
Karolina DorniakDepartment of Noninvasive Cardiac Diagnostics, Medical University of Gdansk, 80-214 Gdansk, Poland.ORCID 0000-0002-5226-8311
Anna FaranDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-214 Gdansk, Poland.
Anna KochańskaDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-214 Gdansk, Poland.
Dariusz ZacharekDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-214 Gdansk, Poland.
Ludmiła Daniłowicz-SzymanowiczDepartment of Cardiology and Electrotherapy, Medical University of Gdansk, 80-214 Gdansk, Poland.ORCID 0000-0002-2269-1880

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Emerging data indicate that the ongoing COVID-19 pandemic may result in long-term cardiovascular complications, among which long COVID-19 myocarditis seems to be one of the most dangerous. Clinical presentation of cardiac inflammation ranges from almost asymptomatic to life-threatening conditions, including heart failure (HF) in different stages. (2) Methods: This is a retrospective case-series study that includes three adults with different clinical presentations of heart failure on grounds of myocarditis after initial COVID-19 infection. (3) Results: All patients had new-onset symptomatic HF of various severity: from a moderately reduced left ventricular ejection fraction in one patient to significantly reduced fractions in the remaining two. Moreover, complex ventricular arrhythmias were present in one case. All patients had confirmed past myocarditis in cardiac magnetic resonance. With optimal medical treatment, cardiac function improved, and the symptoms subsided in all cases. (4) Conclusions: In COVID-19 patients, long COVID myocarditis may be one of the severe complications of this acute disease. The heterogeneity in clinical symptoms and a paucity of specific diagnostic procedures expose the patient to the significant risk of misdiagnosing and further HF development.

Indexed as

COVID-19heart failuremyocarditis

Identifiers

PMID36547424
PMCPMC9785067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.